Literature DB >> 20949635

A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry.

Bori Shushan1.   

Abstract

Liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) technology is emerging as a complementary method to traditional methodology used for clinical applications. Enhanced specificity and high-throughput capabilities are providing significant benefits to clinical diagnostic laboratories conducting routine analyses. This technology is expected to expand rapidly as scientists focus on more complicated challenges that can be solved efficiently by adding LC/MS/MS to their arsenal of techniques.
© 2010 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2010        PMID: 20949635     DOI: 10.1002/mas.20295

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  19 in total

Review 1.  Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS.

Authors:  Jessica O Becker; Andrew N Hoofnagle
Journal:  Bioanalysis       Date:  2012-02       Impact factor: 2.681

Review 2.  Clinical metabolomics: the next stage of clinical biochemistry.

Authors:  Angelo D'Alessandro; Bruno Giardina; Federica Gevi; Anna Maria Timperio; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

Review 3.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

4.  Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.

Authors:  Thomas P Mechtler; Thomas F Metz; Hannes G Müller; Katharina Ostermann; Rene Ratschmann; Victor R De Jesus; Bori Shushan; Joseph M Di Bussolo; Joseph L Herman; Kurt R Herkner; David C Kasper
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-09-24       Impact factor: 3.205

5.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

Review 6.  Metabolomics approach in allergic and rheumatic diseases.

Authors:  Rossana Scrivo; Luca Casadei; Mariacristina Valerio; Roberta Priori; Guido Valesini; Cesare Manetti
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

7.  Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library.

Authors:  Stefano Tiziani; Yunyi Kang; Janet S Choi; William Roberts; Giovanni Paternostro
Journal:  Nat Commun       Date:  2011-11-22       Impact factor: 14.919

8.  Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins.

Authors:  Christopher M Colangelo; Gordana Ivosev; Lisa Chung; Thomas Abbott; Mark Shifman; Fumika Sakaue; David Cox; Robert R Kitchen; Lyle Burton; Stephen A Tate; Erol Gulcicek; Ron Bonner; Jesse Rinehart; Angus C Nairn; Kenneth R Williams
Journal:  Proteomics       Date:  2015-02-12       Impact factor: 3.984

9.  Paper spray ionization devices for direct, biomedical analysis using mass spectrometry.

Authors:  Qian Yang; He Wang; Jeffrey D Maas; William J Chappell; Nicholas E Manicke; R Graham Cooks; Zheng Ouyang
Journal:  Int J Mass Spectrom       Date:  2012-02-15       Impact factor: 1.986

Review 10.  Review of software tools for design and analysis of large scale MRM proteomic datasets.

Authors:  Christopher M Colangelo; Lisa Chung; Can Bruce; Kei-Hoi Cheung
Journal:  Methods       Date:  2013-05-21       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.